VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2021-10-04−347→ 141,630 total(indirect: by CLAT) - Award
Non-Qualified Stock Option (right to buy)
2021-12-08+21,198→ 21,198 totalExercise: $644.54Exp: 2031-12-08→ Common Stock (21,198 underlying) - Award
Common Stock
2021-12-08+1,861→ 318,669 total
Holdings
- 37,747(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 2,221(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
- [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.